Skip to main content

Gail A. Spiridigliozzi

Professor in Psychiatry and Behavioral Sciences
Psychiatry, Child & Family Mental Health & Community Psychiatry
Box 2906 Med Ctr, Durham, NC 27710
Exchange on Erwin, 2608 Erwin Road, Suite 300, Durham, NC 27705

Overview


Cholinergic therapy in children and adolescents with Down syndrome; premutation carriers of fragile X syndrome; cognitive development of children with infantile-onset Pompe disease who are being treated with enzyme replacement therapy.

Current Appointments & Affiliations


Professor in Psychiatry and Behavioral Sciences · 2022 - Present Psychiatry, Child & Family Mental Health & Community Psychiatry, Psychiatry & Behavioral Sciences
Professor in Pediatrics · 2022 - Present Pediatrics, Clinical Science Departments

Recent Publications


Exploring the use of the National Institutes of Health Toolbox Cognition Battery with children and adolescents with Pompe disease: Preliminary findings.

Journal Article Mol Genet Metab · March 2025 BACKGROUND: Although Pompe disease (PD) was originally characterized as a metabolic myopathy, there is now emerging evidence of neurological involvement in children and adolescents with infantile-onset Pompe disease (IOPD). Therefore, assessing cognition a ... Full text Link to item Cite

Severe CNS involvement in a subset of long-term treated children with infantile-onset Pompe disease.

Journal Article Mol Genet Metab · February 2024 INTRODUCTION: The standard of care for patients with infantile-onset Pompe disease (IOPD) is enzyme replacement therapy (ERT), which does not cross the blood brain barrier. While neuromuscular manifestations of IOPD are well-described, central nervous syst ... Full text Link to item Cite

Pneumonia vaccine response in individuals with Down syndrome at three specialty clinics.

Journal Article Am J Med Genet C Semin Med Genet · December 2023 Individuals with Down syndrome (DS) have been particularly impacted by respiratory conditions, such as pneumonia. However, the description of co-occurring recurrent infections, the response to pneumococcal immunization, and the association of these was pre ... Full text Link to item Cite
View All Publications

Recent Grants


Understanding cognitive and neurological pathologies in infantile Pompe disease CNS

Clinical TrialInvestigator · Awarded by Genzyme Corporation · 2022 - 2030

Understanding cognitive and neurological pathologies in infantile Pompe disease CNS

Clinical TrialInvestigator · Awarded by Genzyme Corporation · 2019 - 2021

Understanding cognitive and neurological pathologies in infantile Pompe disease

Clinical TrialInvestigator · Awarded by Genzyme Corporation · 2016 - 2018

View All Grants

Education, Training & Certifications


University of Kansas · 1988 Ph.D.